XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.20.2

Shareholders' Equity and Other Comprehensive Income (Loss) | 9 Months Ended
--- | ---
Sep. 30, 2020
Equity [Abstract] |
Shareholders' Equity and Other Comprehensive Income (Loss) | Note 6 - Shareholders' Equity and Other Comprehensive Income (Loss) Repurchases of Common Stock During the three months ended September 30, 2020, Synovus did not repurchase any shares of its common stock. During the nine months ended September 30, 2020, Synovus repurchased $16.2 million, or 450 thousand shares of its common stock, at an average price of $36.08 per share, under the share repurchase program announced on January 24, 2020. Dividends The following table presents dividends declared related to common stock. For information related to preferred stock dividends, see "Part II - Item 8. Financial Statements and Supplementary Data - Note 10 - Shareholders' Equity and Other Comprehensive Income" to the consolidated financial statements of Synovus' 2019 Form 10-K.
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2020 |  | 2019 |  | 2020 |  | 2019
Cash dividends declared per share |  | $ | 0.33 |  |  | $ | 0.30 |  |  | $ | 0.99 |  |  | $ | 0.90 |
Equity-Based Compensation Plans The following tables summarize the status of Synovus' stock options, restricted share units, market restricted share units, and performance share units as of September 30, 2020 and activity for the nine months ended September 30, 2020.
|  | Stock Options
(in thousands, except per share amounts) |  | Quantity |  | Weighted-Average Exercise Price Per Share
Outstanding at January 1, 2020 |  | 3,037 |  |  | $ | 22.74 |
Exercised |  | (239) |  |  | 28.28 |
Expired/canceled |  | (64) |  |  | 29.75 |
Outstanding at September 30, 2020 |  | 2,734 |  |  | $ | 22.09 |
|  | RSUs, MRSUs, and PSUs
(in thousands, except per share amounts) |  | Quantity |  | Weighted-Average Grant Date Fair Value Per Share
Non-vested at January 1, 2020 |  | 1,312 |  |  | $ | 39.28 |
Granted |  | 893 |  |  | 32.91 |
Quantity change based on TSR and performance factors |  | 44 |  |  | 35.11 |
Dividend equivalents granted |  | 56 |  |  | 33.50 |
Vested |  | (590) |  |  | 38.85 |
Forfeited |  | (58) |  |  | 36.22 |
Non-vested at September 30, 2020 |  | 1,657 |  |  | $ | 35.80 |
Changes in Accumulated Other Comprehensive Income (Loss) by Component (Net of Income Taxes) The following tables illustrate activity within the balances in accumulated other comprehensive income (loss) by component for the three and nine months ended September 30, 2020 and 2019.
Changes in Accumulated Other Comprehensive Income (Loss) by Component (Net of Income Taxes)
(in thousands) |  | Net unrealized gains (losses) on investment securities available for sale(1) |  | Net unrealized gains (losses) on cash flow hedges(1) |  | Post-retirement unfunded health benefit |  | Total
Balance, July 1, 2020 |  | $ | 134,245 |  |  | $ | 68,263 |  |  | $ | 462 |  |  | $ | 202,970 |
Other comprehensive income (loss) before reclassifications |  | (21,806) |  |  | (6,635) |  |  | — |  |  | (28,441) |
Amounts reclassified from AOCI |  | 1,149 |  |  | (764) |  |  | — |  |  | 385 |
Net current period other comprehensive income (loss) |  | (20,657) |  |  | (7,399) |  |  | — |  |  | (28,056) |
Balance at September 30, 2020 |  | $ | 113,588 |  |  | $ | 60,864 |  |  | $ | 462 |  |  | $ | 174,914 |
Balance, July 1, 2019 |  | $ | 60,586 |  |  | $ | (12,137) |  |  | $ | 840 |  |  | $ | 49,289 |
Other comprehensive income (loss) before reclassifications |  | 25,133 |  |  | (876) |  |  | (378) |  |  | 23,879 |
Amounts reclassified from AOCI |  | 2,765 |  |  | — |  |  | — |  |  | 2,765 |
Net current period other comprehensive income (loss) |  | 27,898 |  |  | (876) |  |  | (378) |  |  | 26,644 |
Balance at September 30, 2019 |  | $ | 88,484 |  |  | $ | (13,013) |  |  | $ | 462 |  |  | $ | 75,933 |
Balance, January 1, 2020 |  | $ | 83,666 |  |  | $ | (18,487) |  |  | $ | 462 |  |  | $ | 65,641 |
Other comprehensive income (loss) before reclassifications |  | 86,678 |  |  | 80,404 |  |  | — |  |  | 167,082 |
Amounts reclassified from AOCI |  | (56,756) |  |  | (1,053) |  |  | — |  |  | (57,809) |
Net current period other comprehensive income (loss) |  | 29,922 |  |  | 79,351 |  |  | — |  |  | 109,273 |
Balance at September 30, 2020 |  | $ | 113,588 |  |  | $ | 60,864 |  |  | $ | 462 |  |  | $ | 174,914 |
Balance, January 1, 2019 |  | $ | (83,179) |  |  | $ | (12,137) |  |  | $ | 896 |  |  | $ | (94,420) |
Other comprehensive income (loss) before reclassifications |  | 167,586 |  |  | (876) |  |  | (378) |  |  | 166,332 |
Amounts reclassified from AOCI |  | 4,077 |  |  | — |  |  | (56) |  |  | 4,021 |
Net current period other comprehensive income (loss) |  | 171,663 |  |  | (876) |  |  | (434) |  |  | 170,353 |
Balance at September 30, 2019 |  | $ | 88,484 |  |  | $ | (13,013) |  |  | $ | 462 |  |  | $ | 75,933 |
(1) For all periods presented, the ending balance in net unrealized gains (losses) on cash flow hedges and investment securities available for sale includes unrealized losses of $12.1 million and $13.3 million, respectively, related to residual tax effects remaining in OCI due to previously established deferred tax asset valuation allowances in 2010 and 2011. In accordance with ASC 740-20-45-11(b), under the portfolio approach, these unrealized losses are realized at the time the entire portfolio is sold or disposed.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration